1. Study of Glabranin as an Inhibitor Against Prostate Cancer: Molecular Docking, Molecular Dynamics Simulation, MM-PBSA Calculation and QSAR Prediction
    Rene Barbie Browne et al, 2024, Indian Journal of Clinical Biochemistry CrossRef